Table 1 Patients characteristics for ten monitored SCLC patients with confirmed SIADH
Case | Gender | Age at diagnosis (years) | Sodium level at therapy start (mmol/l) | TNM | Overall survival (months) |
|---|---|---|---|---|---|
1 | m | 52 | 121 | T4 N1 M1b (brain) | 19 |
2 | m | 70 | 121 | T4 N3 M1b (hepatic, osseous, pleura) | 8 |
3 | m | 66 | 118 | T4 N3 M1b (cervical, pulmonal, osseous) | 8 |
4 | f | 62 | 115 | T4 N2 M0 | 20, lives |
5 | f | 62 | 118 | T4 N3 M1b (hepatic) | 11 |
6 | m | 66 | 120 | T3 N2 M0 | 11 |
7 | m | 50 | 116 | T2a N1 M0 | 2 |
8 | f | 63 | 117 | T4 N3 M0 | 11, lives |
9 | m | 71 | 122 | T4 N3 M1a | 5 |
10 | m | 65 | 117 | T4 N3 M1b (hepatic, osseous) | 10 |